Association of White Blood Cell Count With Metabolic Syndrome in Obese Men and Women

authors:

avatar Sima Hashemipour 1 , avatar azam ghorbani 1 , * , avatar Niloofar Jafari Aref 1

Metabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
Journal of Inflammatory Diseases: Vol.24, issue 5; 444-453
article type: issue_documents_importer

How To Cite Hashemipour S, ghorbani A, Jafari Aref N. Association of White Blood Cell Count With Metabolic Syndrome in Obese Men and Women. J Inflamm Dis. 2020;24(5):e156244. 

Abstract

Background: Despite the widespread obesity epidemic in the world, not all obese people are equally susceptible to the complications of obesity. Inflammatory factors play an important role in the complications of obesity. Objective: This study aims to evaluate the association of White Blood Cell (WBC) count with metabolic syndrome in overweight/obese men and women. Methods: This cross-sectional study is a part of the Qazvin Metabolic Disease Study (QMDS) conducted in 2010 in Qazvin, Iran. Participants were 622 obese people with a body mass index (BMI) ≥25 kg/m2, recruited from the QMDS. Metabolic syndrome was defined according to the Adult Treatment Panel III criteria. Data were analyzed using chi-square test, t-test, and logistic regression analysis (to evaluate the relationship between WBC count quartiles and metabolic syndrome). Findings: Prevalence of metabolic syndrome was not significantly different between men and women. In men, prevalence of metabolic syndrome and its components were not different between WBC quartiles. In women, 2.23% and 5.06% had metabolic syndrome in the first and fourth quartiles of WBC count, respectively (P<0.001). Moreover, the prevalence of insulin resistance was higher in fourth quartile compared to the first quartile (7.74% vs. 6.52%, P<0.001). After controlling the effects of age and BMI factors, the risk of metabolic syndrome in the fourth quartile of WBC count remained significant in women (OR=2.56, P<0.01). Conclusion: Association of WBC count with metabolic syndrome is significant in obese women compared to obese men.

References

  • 1.

    Chan Z, Chooi YC, Ding C, Choo J, Sadananthan SA, Michael N, et al. Sex differences in glucose and fatty acid metabolism in Asians who are nonobese. J Clin Endocrinol Metab. 2019; 104(1):127-36. [DOI:10.1210/jc.2018-01421] [PMID].

  • 2.

    Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020; 7:22. [DOI:10.3389/fcvm.2020.00022] [PMID] [PMCID].

  • 3.

    Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168(15):1617-24. [DOI:10.1001/ archinte.168.15.1617] [PMID].

  • 4.

    Neeland IJ, Poirier P, Desprs JP. Cardiovascular and metabolic heterogeneity of obesity: Clinical challenges and implications for management. Circulation. 2018; 137(13):1391-406. [DOI:10.1161/CIRCULATIONAHA.117.029617] [PMID] [PMCID].

  • 5.

    Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: J Clin Invest. 2019; 129(10):3978-89. [DOI:10.1172/JCI129186] [PMID] [PMCID].

  • 6.

    Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365(9468):1415-28. [DOI:10.1016/S01406736(05)66378-7].

  • 7.

    Kahn CR, Wang G, Lee KY. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest. 2019; 129(10):3990-4000. [DOI:10.1172/JCI129187] [PMID] [PMCID].

  • 8.

    Yang H, Fu YQ, Yang B, Zheng JS, Zeng XY, Zeng W, et al. Positive association between the metabolic syndrome and white blood cell counts in Chinese. Asia Pac J Clin Nutr. 2017; 26(1):141-7. [DOI:10.6133/apjcn.102015.13] [PMID].

  • 9.

    Caporaso NE, Jones RR, Stolzenberg-Solomon RZ, Medgyesi DN, Kahle LL, Graubard BI. Insulin resistance in healthy U.S. adults: Findings from the National Health and Nutrition Examination Survey (NHANES). Cancer Epidemiol Biomarkers Prev. 2020; 29(1):157-68. [DOI:10.1158/1055-9965.EPI-19-0206] [PMID].

  • 10.

    Pratley RE, Wilson C, Bogardus C. Relation of the white blood cell count to obesity and insulin resistance: Effect of race and gender. Obes Res. 1995; 3(6):563-71. [DOI:10.1002/j.1550-8528.1995.tb00191.x] [PMID].

  • 11.

    Jiang H, Yan WH, Li CJ, Wang AP, Dou JT, Mu YM. Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people. Int J Environ Res Public Health. 2014; 11(5):5497-509. [DOI:10.3390/ijerph110505497] [PMID] [PMCID].

  • 12.

    Nilsson G, Hedberg P, Jonason T, Lnnberg I, Tenerz , hrvik J. White blood cell counts associate more strongly to the metabolic syndrome in 75-year-old women than in men: A population based study. Metab Syndr Relat Disord. 2007; 5(4):359-64. [DOI:10.1089/met.2007.0012] [PMID].

  • 13.

    Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and metaanalysis. Sleep Med Rev. 2016; 30:11-24. [DOI:10.1016/j. smrv.2015.10.002] [PMID].

  • 14.

    Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prudhomme D, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005; 90(7):4145-50. [DOI:10.1210/jc.20050482] [PMID].

  • 15.

    Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 2013; 98(10):E1610-9. [DOI:10.1210/jc.2013-2038] [PMID].

  • 16.

    Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S. Association between uric acid and metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. Glob J Health Sci. 2013; 5(1):155-65. [DOI:10.5539/gjhs.v5n1p155].

  • 17.

    Gayoso-Diz P, Otero-Gonzlez A, Rodriguez-Alvarez MX, Gude F, Garca F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013; 13:47. [DOI:10.1186/14726823-13-47] [PMID] [PMCID].

  • 18.

    Shashaj B, Luciano R, Contoli B, Morino GS, Spreghini MR, Rustico C, et al. Reference ranges of HOMA-IR in normalweight and obese young Caucasians. Acta Diabetol. 2016; 53(2):251-60. [DOI:10.1007/s00592-015-0782-4] [PMID].

  • 19.

    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002; 106(25):3143-421. [PMID].

  • 20.

    Abbasalizad Farhangi M, Keshavarz SA, Eshraghian MR, Ostadrahimi AR, Saboor-Yaraghi AA. White blood cell count in women: Relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J Health Popul Nutr. 2013; 31(1):58-64. [DOI:10.3329/ jhpn.v31i1.14749] [PMID] [PMCID].

  • 21.

    Hanley AJG, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, et al. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab. 2009; 94(10):3824-32. [DOI:10.1210/jc.2009-0719] [PMID].

  • 22.

    Pei C, Chang JB, Hsieh CH, Lin JD, Hsu CH, Pei D, et al. Using white blood cell counts to predict metabolic syndrome in the elderly: A combined cross-sectional and longitudinal study. Eur J Intern Med. 2015; 26(5):324-9. [DOI:10.1016/j. ejim.2015.04.009] [PMID].

  • 23.

    Shitole SG, Biggs ML, Reiner AP, Mukamal KJ, Djouss L, Ix JH, et al. Soluble CD14 and CD14 variants, other inflammatory markers, and glucose dysregulation in older adults: The Cardiovascular Health Study. Diabetes Care. 2019; 42(11):2075-82. [DOI:10.2337/dc19-0723] [PMID] [PMCID].

  • 24.

    Jung CH, Lee WY, Kim BY, Park SE, Rhee EJ, Park CY, et al. The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults. Yonsei Med J. 2013; 54(3):61520. [DOI:10.3349/ymj.2013.54.3.615] [PMID] [PMCID].

  • 25.

    Li PF, Chen JS, Chang JB, Chang HW, Wu CZ, Chuang TJ, et al. Association of complete blood cell counts with metabolic syndrome in an elderly population. BMC Geriatr. 2016; 16:10. [DOI:10.1186/s12877-016-0182-9] [PMID] [PMCID].

  • 26.

    Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: The Cardiovascular Health Study. Diabetes. 2001; 50(10):2384-9. [DOI:10.2337/diabetes.50.10.2384] [PMID].

  • 27.

    Wannamethee SG, Papacosta O, Lawlor DA, Whincup PH, Lowe GD, Ebrahim S, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Womens Heart Health Study. Diabetologia. 2012; 55(1):80-7. [DOI:10.1007/s00125-011-2284-4] [PMID].

  • 28.

    Wannamethee SG, Papacosta O, Whincup PH, Carson C, Thomas MC, Lawlor DA, et al. Assessing prediction of diabetes in older adults using different adiposity measures: A 7 year prospective study in 6,923 older men and women. Diabetologia. 2010; 53(5):890-8. [DOI:10.1007/s00125-010-1670-7] [PMID] [PMCID].

  • 29.

    Yan Y, Li Sh, Liu Y, Bazzano L, He J, Mi J, et al. Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: The Bogalusa Heart Study. Cardiovasc Diabetol. 2019; 18:109. [DOI:10.1186/s12933-019-0913-2].

  • 30.

    Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance: Evidence for a common antecedent? Diabetes Care. 1999; 22 Suppl 3:C25-30. [PMID]##.